EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Solithromycin mitigates Prevotella intermedia–induced methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia by enhancing alveolar macrophage function

Koki Fukushima, Naoki Iwanaga, Nobuyuki Ashizawa, Kazuaki Takeda, Tatsuro Hirayama, Masataka Yoshida, Shotaro Ide, Takahiro Takazono, Kosuke Kosai, Noriho Sakamoto, Mariko Naito, Katsunori Yanagihara und 1 weitere

Frontiers in Cellular and Infection Microbiology · 09.02.2026 · 16

DOI: 10.3389/fcimb.2026.1723186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 09.02.2026. Verfasst von Koki Fukushima und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Hauptthemen laut MEDLINE: Macrophages, Alveolar, Methicillin-Resistant Staphylococcus aureus, Pneumonia, Ventilator-Associated, Macrolides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ventilator-associated pneumonia (VAP) is a fatal intensive care infection. VAP caused by methicillin-resistant Staphylococcus aureus (MRSA) can be exacerbated by Prevotella intermedia culture supernatant ( P. int. sup.). Solithromycin (SOL), a fourth-generation macrolide, inhibits bacterial protein synthesis and modulates immunity; however, its effects on exacerbation of MRSA-VAP by P. int . sup. remain unclear. This study examined whether SOL inhibits bacterial protein synthesis by binding to the 50S ribosomal subunits in P. int . sup. and subsequently reduces the worsening of MRSA-VAP caused by P. int. sup.

Methods

BALB/cCrSlc mice received MRSA and P. int. sup. with or without sub-minimum inhibitory concentrations of SOL ( P. int . sup. (SOL)) or clarithromycin (CAM; P. int. sup. (CAM)). Outcomes included survival rates, lung MRSA burden, and transcriptomics (reverse transcription polymerase chain reaction, bulk RNA sequencing [RNA-seq]). In vitro , bone marrow-derived alveolar macrophage-like cells (AMLCs) from C57BL/6J mice were infected with MRSA ± SOL; bactericidal activity and mRNA expression were measured.

Results

P. int . sup. increased mortality, bacterial load, and neutrophilic infiltration; however, P. int . sup. (SOL) significantly improved survival rate (100%, n = 8, ****P < 0.0001), reduced MRSA burden ( n = 10–11, **P < 0.01), and enhanced macrophage recruitment ( n = 7–8, ****P < 0.001). P. int. sup. downregulated Ccr2 expression ( n = 7–8, ***P < 0.001). RNA-seq analysis revealed P. int . sup. (SOL) upregulated macrophage phagocytosis and bactericidal pathways. SOL-pretreated AMLCs infected with MRSA exhibited reduced bacterial burden ( n = 8, *P < 0.05 vs control, **P < 0.01 vs CAM-pretreated AMLCs) and upregulated Tnf-α expression ( n = 7–8, *P < 0.05 vs control).

Conclusion

SOL protects by activating alveolar macrophages and promoting TNF-related responses, suggesting a novel immunomodulatory role for SOL in host defense against exacerbation of MRSA-VAP by P. int. sup.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophages, AlveolarMethicillin-Resistant Staphylococcus aureusPneumonia, Ventilator-AssociatedMacrolidesPrevotella intermediaAnti-Bacterial AgentsTriazolesBacteroidaceae InfectionsAnimalsMiceMice, Inbred BALB CDisease Models, AnimalLungClarithromycinPhagocytosisStaphylococcal Infections

Stichwörter der Autor:innen

Prevotella intermediaRNAsequencingalveolar macrophagesimmunomodulationmethicillin-resistant Staphylococcus aureussolithromycinventilator-associated pneumonia

Substanzen

MacrolidesAnti-Bacterial AgentssolithromycinTriazolesClarithromycin

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Department of Pharmacotherapeutics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Infectious Diseases Experts Training Center, Nagasaki University Hospital, Nagasaki, Japan.
  • Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.

Zitieren

APA

Fukushima, K., Iwanaga, N., Ashizawa, N., Takeda, K., Hirayama, T., Yoshida, M., Ide, S., Takazono, T., Kosai, K., Sakamoto, N., Naito, M., Yanagihara, K., & Mukae, H. (2026). Solithromycin mitigates Prevotella intermedia–induced methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia by enhancing alveolar macrophage function. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1723186

Vancouver

Fukushima K, Iwanaga N, Ashizawa N, Takeda K, Hirayama T, Yoshida M, et al. Solithromycin mitigates Prevotella intermedia–induced methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia by enhancing alveolar macrophage function. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1723186

BibTeX
@article{Fukushima2026,
  author = {Fukushima, Koki and Iwanaga, Naoki and Ashizawa, Nobuyuki and Takeda, Kazuaki and Hirayama, Tatsuro and Yoshida, Masataka and Ide, Shotaro and Takazono, Takahiro and Kosai, Kosuke and Sakamoto, Noriho and Naito, Mariko and Yanagihara, Katsunori and Mukae, Hiroshi},
  title = {Solithromycin mitigates Prevotella intermedia–induced methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia by enhancing alveolar macrophage function},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1723186}
}
Kostenlos starten →